Document Detail


The utilization of nonthermal blue (405-425 nm) and near infrared (850-890 nm) light in aesthetic dermatology and surgery-a multicenter study.
MedLine Citation:
PMID:  16414904     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: A major cause of skin aging is a chronic micro-inflammation triggered by UV radiation and external pollutants. It has been demonstrated that blue light diminishes inflammatory conditions and near infrared light enhances circulation. OBJECTIVES: To assess the effectiveness of a non thermal dual wavelength -- blue (405 - 420 nm) and near infrared (850 - 900 nm) -- light source in skin rejuvenation, in the reduction of the duration of post skin resurfacing erythema and in the acceleration of healing of post surgical conditions (face lift and breast augmentation). METHODS: We have utilized a non contact, hand free dual wavelength light source (iClearXL and Clear100XL, Curelight Ltd) to treat over 60 patients and perform three controlled studies in four centers. Follow up duration was three months. Control group for photo-rejuvenation consisted of patients treated with Glycolic peeling and daily appliance of vitamin C Control group for post skin resurfacing erythema duration consisted of patients untreated by the light source and control group for post surgical healing consisted of patients untreated by the light source or treated by the light source on one side only. RESULTS: Post skin resurfacing erythema duration is reduced by 90%. The healing of post surgical conditions is substantially accelerated and discomfort is reduced. The anti aging effect of the light source includes: reduction of pore size in 90% of patients with stable results at three months follow up, enhanced skin radiance in 90% of patients with stable results at three months follow up and smoothing of fine wrinkles in 45% of patients with stable results at three months follow up. The control group showed poor results which were stable for a duration of less than one month. CONCLUSIONS: A non thermal, non contact / hand free light source emitting at 405-420 nm and 850-900 nm considerably enhances aesthetic and surgical aesthetic procedures without consuming user time.
Authors:
Gary Lask; Nathalie Fournier; Mario Trelles; Monica Elman; Michael Scheflan; Michael Slatkine; Jenny Naimark; Yoram Harth
Related Documents :
9055014 - Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-c...
17763024 - Fractional photothermolysis treatment for resistant melasma in chinese females.
17422254 - Mammary hypertrophy in an ovariohysterectomized cat.
11357294 - Laser resurfacing: a safe and predictable method of skin resurfacing.
21858614 - Ropivacaine for ultrasound-guided interscalene block: 5 ml provides similar analgesia ...
23493284 - Cryoplasty offers no advantage over standard balloon angioplasty for the treatment of i...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article; Multicenter Study    
Journal Detail:
Title:  Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology     Volume:  7     ISSN:  1476-4172     ISO Abbreviation:  J Cosmet Laser Ther     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2006-01-17     Completed Date:  2006-05-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101136419     Medline TA:  J Cosmet Laser Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  163-70     Citation Subset:  IM    
Affiliation:
UCLA Medical School, Los Angeles, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chemexfoliation / adverse effects
Cosmetic Techniques*
Erythema / etiology,  therapy
Humans
Infrared Rays / therapeutic use*
Phototherapy / methods*
Rejuvenation
Skin Aging
Skin Temperature
Treatment Outcome
Wound Healing*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pilot study to determine the efficacy of ALA-PDT photo-rejuvenation for the treatment of facial agei...
Next Document:  Adverse reactions to dermal fillers: a review of European experiences.